Composite Magnetic Nanocarriers for MRI and Targeted Drug Delivery | |
Lijiao Ao; Liang Huang; Wu Su | |
2015 | |
会议名称 | ChinaNanomedicine 2015 |
会议地点 | Hangzhou, China |
英文摘要 | The integration of individual superparamagnetic iron oxide nanoparticles (SPIONs) creates the synergistic magnetism, which is desired for enhanced magnetic response and T2 weighted MRI signals.[1] We developed strategies for the assembly of SPIONs and their combination with chemotherapeutic agents, employing novel nanocarriers.[2] The heparin, a biodegradable and natural sourced polysaccharide, was derivated with folic acid (FA) to achieve the amphiphilicity. After micellization of the polymer in water, the FA moieties served as both hydrophobic domains for cargos (SPIONs and doxorubicin) loading, and targeting ligands for cancer cells over-expressing FA receptors. These nanocarriers possessed a desirable size (70 nm), high colloidal stability and sustained doxorubicin release. The high magnetic content in each micelle realized their magnetic field guided targeting to cancer cells, combined with MRI diagnosis and chemotherapy. Another strategy exploited silica nanotubes (SNTs) as novel nanocarriers, for their elongated morphology (favourable for tumor penetration), hollow/porous structure and high chemical affinity to iron oxides. Based on these templates, we fabricated SNT@SPIONs composites by in-situ thermo-decomposition, skipping the conventional pre-synthesis and modification of both SPIONs and the templates. Owning to the synergistic magnetism of the densely loaded SPIONs, the composite nanotubes showed high T2 relaxation rate and quick magnetic response. After doxorubicin loading, the drug carriers were applied for magnetic guided tumor targeting, MRI diagnosis and chemotherapy to cancers. |
收录类别 | 其他 |
语种 | 英语 |
WOS记录号 | WOS:000373923400144 |
内容类型 | 会议论文 |
源URL | [http://ir.siat.ac.cn:8080/handle/172644/7443] |
专题 | 深圳先进技术研究院_医药所 |
作者单位 | 2015 |
推荐引用方式 GB/T 7714 | Lijiao Ao,Liang Huang,Wu Su. Composite Magnetic Nanocarriers for MRI and Targeted Drug Delivery[C]. 见:ChinaNanomedicine 2015. Hangzhou, China. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论